These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18959495)

  • 21. Complications of HIV disease and antiretroviral therapy.
    Havlir DV; Currier JS
    Top HIV Med; 2006; 14(1):27-35. PubMed ID: 16641525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!
    Morelle J; Goffin E; Wallemacq P; De Meyer M; Yombi JC; Mourad M; Kanaan N
    Transpl Int; 2010 Oct; 23(10):1065-7. PubMed ID: 20477995
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antiretroviral therapy suppression: already a new strategy?].
    Viciana Fernández P; Mata Alcázar-Caballero R; López Cortés LF
    Farm Hosp; 2004; 28(6 Suppl 1):85-91. PubMed ID: 15649120
    [No Abstract]   [Full Text] [Related]  

  • 24. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Szczech LA
    Curr Opin HIV AIDS; 2009 May; 4(3):167-70. PubMed ID: 19532045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial comment: complications of antiretroviral therapy in children--a glass half full.
    Cervia JS
    AIDS Read; 2006 Oct; 16(10):551. PubMed ID: 17096473
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions.
    Kotler DP
    Liver Int; 2009 Mar; 29 Suppl 2():38-46. PubMed ID: 19187071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early versus deferred antiretroviral therapy for HIV.
    Arribas JR; Mora M; Pascual-Pareja JF
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701985
    [No Abstract]   [Full Text] [Related]  

  • 33. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
    Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
    Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral nephrotoxicities.
    Atta MG; Deray G; Lucas GM
    Semin Nephrol; 2008 Nov; 28(6):563-75. PubMed ID: 19013327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral therapy adherence in children: outcomes from Africa.
    Reddi A; Leeper SC
    AIDS; 2008 Apr; 22(7):906-7. PubMed ID: 18427213
    [No Abstract]   [Full Text] [Related]  

  • 36. QT interval prolongation and antiretroviral treatment: another point of interest.
    Chinello P; Petrosillo N
    Clin Infect Dis; 2007 May; 44(10):1388-9; author reply 1389-91. PubMed ID: 17443482
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
    Endo T; Fujimoto K; Nishio M; Yamamoto S; Obara M; Sato N; Koike T
    J Med Virol; 2009 Jun; 81(6):979-82. PubMed ID: 19382259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Disease in Human Immunodeficiency Virus Infection.
    Oikonomou KG; Tsai E; Sarpel D; Dieterich DT
    Clin Liver Dis; 2019 May; 23(2):309-329. PubMed ID: 30947879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction. Integrating nutrition therapy into medical management of human immunodeficiency virus.
    Bartlett JG
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S51. PubMed ID: 12652371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.